Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levamisole to prevent relapse in children with first episode steroid-sensitive idiopathic nephrotic syndrome
2017-001025-41Phase 3Active
- Sponsor
- Academic Medical Center
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levamisole in nephrosis, sponsored by Academic Medical Center. Started Dec 2017; status: active.
02
Drugs
levamisole
03
Conditions
nephrosis
Beyond the preview
Go deeper on 2017-001025-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001025-41.